We are live on ! Find out more
SKBI

SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI

Delisted

SKBI was delisted on the 18th of December, 2015.

Back to rankings

11 hedge funds and large institutions have $1.56M invested in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

46% less capital invested

Capital invested by funds: $2.88M → $1.56M (-$1.32M)

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.57M
2
RCM
Rotella Capital Management
Washington
+$87.4K
3
CAM
ClariVest Asset Management
California
+$85.2K
4
Renaissance Technologies
Renaissance Technologies
New York
+$79.3K
5
Morgan Stanley
Morgan Stanley
New York
+$46.2K

Top Sellers

Rank Fund Capital Flow
1
ACM
Ativo Capital Management
Illinois
-$454K
2
Jane Street
Jane Street
New York
-$134K
3
HighTower Advisors
HighTower Advisors
Illinois
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$737K +$41.4K +7,622 +5%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$150K +$2.17K +399 +1%
RCM
3
Rotella Capital Management
Washington
$140K +$87.4K +16,100 +93%
BCM
4
Bridgeway Capital Management
Texas
$102K – – –
EGA
5
Eagle Global Advisors
Texas
$95K +$12.9K +2,380 +12%
SIM
6
Spark Investment Management
New York
$89K +$34.2K +6,300 +42%
CAM
7
ClariVest Asset Management
California
$82K +$85.2K +15,704 +391%
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$67K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$61K +$79.3K +14,600 New
Morgan Stanley
10
Morgan Stanley
New York
$36K +$46.2K +8,514 New
SM
11
Sabby Management
Florida
$1.21K +$1.57M +289,110 New
ACM
12
Ativo Capital Management
Illinois
– -$454K -61,837 Closed
Jane Street
13
Jane Street
New York
– -$134K -18,255 Closed
HighTower Advisors
14
HighTower Advisors
Illinois
– -$85K -11,545 Closed

SKBI Hedge Fund Activity: Q3 2014 in Review

11 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) for Q3 2014, worth a combined $1.56M — down 46% from $2.88M a quarter earlier.

Fund positioning in SKBI was balanced in Q3 2014: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.57M. The largest seller was Ativo Capital Management, exiting entirely with an estimated $454K sold.

  • 11 institutional investors held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $1.56M of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) stock for Q3 2014, down 46% quarter-over-quarter.
  • 3 funds opened new SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) positions in Q3 2014 and 3 closed out, a net change of 0 holders.
  • The largest SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) buyer in Q3 2014 was Sabby Management, an estimated $1.57M added.
  • The largest SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) seller in Q3 2014 was Ativo Capital Management, an estimated $454K sold.

Based on aggregated 13F filings for Q3 2014.